Article Information
History
- October 14, 2022.
Article Versions
- Version 1 (July 4, 2022 - 09:21).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Connor Rogerson1,
- Marco Sciacovelli1,
- Lucas A Maddalena1,
- Lorea Valcarcel-Jimenez1,2,
- Christina Schmidt1,2,
- Ming Yang1,2,
- Elena Ivanova3,
- Joshua Kent4,
- Ariane Mora5,
- Danya Cheeseman4,
- Jason S Carroll4,
- Gavin Kelsey3,6,7 and
- Christian Frezza1,2,*
- 1MRC Cancer Unit, University of Cambridge, Hutchison MRC Research Centre, Cambridge Biomedical Campus, Cambridge, United Kingdom
- 2CECAD Research Center, Faculty of Medicine, University Hospital Cologne, Cologne, Germany
- 3Epigenetics Programme, Babraham Institute, Cambridge, UK
- 4CRUK Cambridge Institute, University of Cambridge, Cambridge, UK
- 5School of Chemistry and Molecular Biosciences, University of Queensland, Molecular Biosciences Building 76, St Lucia QLD 4072, Australia
- 6Centre for Trophoblast Research, University of Cambridge, Cambridge, UK
- 7Wellcome-MRC Institute of Metabolic Science - Metabolic Research Laboratories, Cambridge, UK
- ↵*Corresponding author: christian.frezza{at}uni-koeln.de